Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphic variation in CYP19 and the risk of breast cancer.

Carcinogenesis - 1 Feb 2001

Baxter S W, Choong D Y, Eccles D M, Campbell I G

Abstract excerpt

The production of estrogen from androgen via the estrogen biosynthesis pathway is catalyzed by aromatase P450 (cyp19). We have assessed the frequency of allelic variants of the CYP19 intron 4 [TTTA]n repeat in 327 breast cancer cases and 253 controls from southern England. Previous studies have suggested that the [TTTA](10) repeat and [TTTA](12) repeat variants represent low penetrance breast cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Aromatase
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Introns

Share to Lymphocytes

Share to Risk Factors

Source

Identifiers

PMID: 11181459
DOI: 10.1093/carcin/22.2.347

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphic variation in CYP19 and the risk of breast cancer.PMID 11181459Read ↗

Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.Semantic proximity Read ↗

A rare CYP19 (aromatase) variant may increase the risk of breast cancer.Semantic proximity Read ↗

A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.Semantic proximity Read ↗

Genetic variants of CYP19 (aromatase) and breast cancer risk.Semantic proximity Read ↗

Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk.Semantic proximity Read ↗

The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.Semantic proximity Read ↗

A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk.Semantic proximity Read ↗

Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study.Semantic proximity Read ↗

A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches.Semantic proximity Read ↗

Effect of CYP19 rs6493497 and rs7176005 haplotype status on in vivo aromatase transcription, plasma and tissue estrogen levels in postmenopausal women.Semantic proximity Read ↗

No association between a single nucleotide polymorphism in CYP19 and breast cancer risk.Semantic proximity Read ↗

A tetranucleotide repeat polymorphism in the CYP19 gene and breast cancer susceptibility in a Greek population exposed and not exposed to pesticides.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.